Moderna, Inc. Common Stock MRNA
$174.38
+176.97%
at last close
Financials (TTM)
- Revenue
- $2.23 billion
- Net Income
- $-3,151,000,000
- Net Margin
- -141.43%
- Return on Equity
- -46.61%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 3.72
- Price / Sales
- 11.28
Over the trailing twelve months, Moderna, Inc. Common Stock generated revenue of $2.23 billion and net income of $-3,151,000,000, a net margin of -141.43%.
At the last closing price of $174.38, MRNA trades at 11.28 times sales, with a market capitalization of $25.14 billion.
Key Stats
- Last Close
- $174.38
- Market Cap
- $25.14 billion
- 52-Week Range
- $22.28 – $176.66
- Average Volume
- 11.92 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.